Leveraging Mammalian Therapeutic Research To Identify Novel Lead Chemistries for Crop Protection

被引:0
作者
Hunter, James E. [1 ]
Loso, Michael [1 ]
Tisdell, Francis E. [1 ]
Yap, Maurice C. H. [1 ]
机构
[1] Dow AgroSci LLC, Discovery Res, Indianapolis, IN 46268 USA
来源
DISCOVERY AND SYNTHESIS OF CROP PROTECTION PRODUCTS | 2015年 / 1204卷
关键词
MICROCOLIN-A; DISCOVERY; DERIVATIVES; FUNGICIDES; AGONISTS; DESIGN; TARGET;
D O I
暂无
中图分类号
S3 [农学(农艺学)];
学科分类号
0901 ;
摘要
Driven by pest resistance and the ever changing demands of the market place, the discovery of new modes of action and lead chemistries with the potential to evolve into novel agricultural products is of prime importance to any crop protection discovery program. One proven inspirational resource for hypotheses which can unearth new agriculturally relevant lead chemistries is the medicinal literature. With the tremendous amount of basic and applied research being conducted to understand as well as exploit mammalian biology, biochemistry and the pathogens that act on them, new therapeutic modes of action, target site ligands and/or biologically privileged chemical motifs continually find their way to the open literature. In this paper some strategies to exploit this wealth of information to identify novel insecticidal and fungicidal lead chemistries will be discussed. Several case studies will be given to illustrate some of the advantages and drawbacks in this lead generation approach.
引用
收藏
页码:63 / 78
页数:16
相关论文
共 42 条
[1]  
[Anonymous], GLOB US MED OUTL 201
[2]   Progress in understanding molecular mechanisms and evolution of resistance to succinate dehydrogenase inhibiting (SDHI) fungicides in phytopathogenic fungi [J].
Avenot, Herve F. ;
Michailides, Themis J. .
CROP PROTECTION, 2010, 29 (07) :643-651
[3]  
Benko Z. L., MICROCOLIN INSECTICI, P200
[4]   Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs [J].
Bisson, W. H. ;
Cheltsov, A. V. ;
Bruey-Sedano, N. ;
Lin, B. ;
Chen, J. ;
Goldberger, N. ;
May, L. T. ;
Christopoulos, A. ;
Dalton, J. T. ;
Sexton, P. M. ;
Zhang, X.-K. ;
Abagyan, R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (29) :11927-11932
[5]   Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands [J].
Böhme, TM ;
Keim, C ;
Dannhardt, G ;
Mutschler, E ;
Lambrecht, G .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (09) :1241-1243
[6]   Guanaconetins, new antitumoral acetogenins, mitochondrial complex I and tumor cell growth inhibitors [J].
Chahboune, N ;
Barrachina, I ;
Royo, I ;
Romero, V ;
Sáez, J ;
Tormo, JR ;
De Pedro, N ;
Estornell, E ;
Zafra-Polo, MC ;
Peláez, F ;
Cortes, D .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (04) :1089-1094
[7]   Medicinal uses of tobacco in history [J].
Charlton, A .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2004, 97 (06) :292-296
[8]   SYNTHESIS OF A NEW SERIES OF 2,8-DISUBSTITUTED-2,8-DIAZASPIRO[4,5]DECAN-1-ONES AS POTENTIAL MUSCARINIC AGONISTS [J].
CIGNARELLA, G ;
VILLA, S ;
CATTABENI, F ;
RENO, F ;
CIMINO, M ;
DEBENEDETTI, PG ;
BARLOCCO, D .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1994, 29 (12) :955-961
[9]  
Davis G., 2010, WO Patent, Patent No. 135070
[10]  
Dick MR, 1997, PESTIC SCI, V49, P268, DOI 10.1002/(SICI)1096-9063(199703)49:3<268::AID-PS527>3.0.CO